Improving assessments for blepharospasm treatment outcomes
Triangulating outcome assessments for blepharospasm
This study is looking to improve how we measure the effects of botulinum toxin treatments for blepharospasm, a condition that causes involuntary eye closures, by using video technology to get a clearer picture of how well the treatment is working for patients like you.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10951356 on NIH RePORTER |
What this research studies
This research focuses on enhancing the evaluation of treatment outcomes for blepharospasm, a condition characterized by involuntary eye closures and facial expressions. It aims to address the limitations of current subjective assessment methods by utilizing advanced computer vision technology to objectively measure facial movements and eye closure from video recordings. By improving the accuracy of these assessments, the research seeks to better understand treatment efficacy and patient satisfaction with botulinum toxin injections, which are the primary treatment for this condition. The study will involve collecting and analyzing data to develop more reliable outcome measures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with blepharospasm who are currently receiving or considering botulinum toxin treatment.
Not a fit: Patients who do not have blepharospasm or those who are not candidates for botulinum toxin therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies and improved patient satisfaction for those suffering from blepharospasm.
How similar studies have performed: Previous research has shown promise in using technology-based assessments for other neurological conditions, indicating potential success for this novel approach.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Peterson, David a — University of California, San Diego
- Study coordinator: Peterson, David a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.